We have updated our Psychedelic Company Financing Tracker to reflect activity in Q3 2025. Below, you will find your exclusive Pα+ summary. Psychedelic financing activity dropped slightly in Q3 vs the previous quarter, and is down substantially from Q2, with just over $120M raised across 8 financing events. The most substantial of those was a $50M private placement by atai Life Sciences…
